Current calls, week 37, 2020
Tips from KI Grants Office about current calls.
Swedish and Nordic calls
Wera Ekströms stiftelse för pediatrisk forskning
Wera Ekströms Stiftelse för pediatrisk forskning inbjuder ansökningar om forskningsanslag. Dessa stöder pediatrisk forskning, i första hand med inriktning på de sjukdomstillstånd som drabbar ämnesomsättningen. Följande typer av anslag finns tillgängliga:
•forskarrekryteringsstipendier värda SEK 15,000 per månad, att använda före registrering till forskarutbildningen som doktorand;
•stipendier för registrerade forskarstuderande värda SEK 17,000 per månad;
•stipendier för disputerade forskare värda SEK 22,000 per månad.
Stipendierna är avsedda för heltidsstudier och yngre forskare prioriteras.
Den totala budgeten uppgår till SEK 500,000.
Closing date: 1 October 2020
- Stipendier för forskarkurser och kongresser
- Stipendier för kortare forskningsvistelse utomlands - stöder doktorander att vistas under en kortare tid utomlands.
- Apotekens bidrag för bra läkemedelsanvändning - stöder forskningsprojekt inom öppenvårdsapotek
Closing date: 31 October 2020
Extra satsning på preventionsforskning - Hjärt-Lungfonden
Stöder preventions- och behandlingsforskning inom hjärt-, kärlområdet med fokus på livsstilsrelaterad intervention. Anslag uppgår till SEK 2 miljoner per år i upp till tre år.
Closing date: 24 November 20
Swelife and Medtech4Health: collaborative projects for improved health - Vinnova
Supports collaborative innovation projects with potential to improve prevention, diagnosis, monitoring or treatment, in order to promote innovation for better healthcare and sustainable growth in the life science sector in Sweden. Grants are worth up to SEK 3 millon per project for up to two years. Co-financing is required.
Closing date: 25 November 20
Societal transformation for climate action - The Swedish Foundation for Strategic Environmental Research (Mistra)
Mistra invites research groups, jointly with civil society organizations, the public sector and other stakeholders, to submit proposals for a new research programme. The purpose of the call is to facilitate societal transformation for climate action through research and innovation. The call addresses research groups in all academic disciplines and grants are worth up to SEK 40 million over four years.
Closing date: 29 January 21
Basic research fellowship - European Society of Cardiology
The European Society of Cardiology invites applications for its basic research fellowship. This enables a researcher to spend one year in a European research laboratory of their choice, working on a research project in cardiovascular sciences. Preference is given to preclinical research projects and to those for whom the award will enable the fellow to learn novel techniques valuable for their future career.
Candidates should not be older than 40 years, and may be of any nationality. Candidates must have activity in the area of cardiovascular sciences and must be members of the Council on Basic Cardiovascular Sciences. The current laboratory of the applicant must be different from the host laboratory.
Closing date: 1 December 2020
Development incubator - AO Foundation
The AO Foundation invites proposals for its development incubator. This supports the development and execution of a proof-of-concept within the field of treatment of patients with musculoskeletal diseases. The area of focus is improvement in patient care, as it applies to orthopaedic trauma, spinal conditions, craniomaxillofacial surgery and veterinary surgery. Proposals addressing surgical instruments, pure research, education or pharmaceuticals are ineligible.
Closing date: 31 October 2020
Beijerinck virology prize - Royal Netherlands Academy of Arts and Sciences (KNAW) | Koninklijke Nederlandse Akademie van Wetenschappen
The Royal Netherlands Academy of Arts and Sciences (KNAW) invites nominations for the Beijerinck virology prize. This recognises an international researcher for achievements in the field of virology, including its biochemical and physical aspects. Research institutes and researchers from all over the world may submit a nomination. The prize is worth €35,000.
Closing date: 1 November 2020
Basic research award - Bayer
Bayer invites letters of intent for its basic research award. This supports basic research projects in the bleeding disorders field. Focus areas for projects include: role of factor VIII outside of coagulation; inhibitors; immunogenicity; lab monitoring research and applications.
Individuals who are affiliated with medical universities, hospitals, treatment centres, blood centres and laboratories that carry out research in inherited bleeding disorders or provide care to patients with these disorders may apply.
Closing date: 30 November 2020
Research grants - Tom Wahlig Foundation
The Tom Wahlig Foundation invites applications for its research grants. These support research into, or with conceptual connections to, the hereditary spastic paraplegias. Topics to be covered may be clinical, genetic or functional in nature, and projects may represent self-contained small studies or be intended to generate preliminary data that enable alternative subsequent funding for a larger follow-up study.
Junior scientists within five years of their thesis for PhDs, or eight years of their thesis for MDs, are especially encouraged to apply.
Closing date: 1 December 2020
Federal Funding agencies
Toward ElucidAting MechanismS Contributing to HIV Reservoirs in NIDDK-relevant Tissues (Cure TEAMS) (R01 Clinical Trial Optional), NIH
The purpose of this Funding Opportunity Announcement (FOA) is to support multidisciplinary research teams with complementary expertise in HIV and physiology, pathophysiology, pathobiology, and/or metabolism in organs, tissues, and/or biological systems of specific interest to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). These teams will provide comprehensive mechanistic analyses of the processes leading to the establishment and persistence of latent HIV reservoirs in anatomical sites relevant to the mission of the NIDDK, with the purpose of advancing progress toward developing a cure.
Closing date: March 3, 2021 and November 17, 2021 All applications are due by 5:00 PM local time of applicant organization.
Funding Opportunity Announcement (FOA): RFA-DK-20-023
Clinical Translation of Activated Optical Fluorescence Methods and Technologies for Sensitive Cancer Detection in Vivo (R01 Clinical Trial Optional), NIH
The purpose of this Funding Opportunity Announcement (FOA) is to bring a highly sensitive imaging technology capable of detecting very small (1-3 mm3) tumors in vivo to clinical utility. Through this FOA, the National Cancer Institute (NCI) solicits innovative concepts that propose a path to clinical validation for in vivo ‘intelligent’ or activated optical fluorescence agents or probes with previously demonstrated capabilities for the detection of small tumors.
This FOA thus supports translation of novel activated optical fluorescence agents for sensitive cancer detection in vivo. Clinical translation and validation should be the primary goals of the proposed research. The bulk of the proposed research must focus on translating improvements in imaging sensitivity to a clinical environment with the goal of demonstrating that tumor cell aggregates on the order of 1 mm 3 in volume can be visualized in vivo. However, minimal research toward development of the probe in preparation for clinical validation will be accepted under this FOA. This FOA thus supports translation of already developed technologies for small tumor detection in vivo. It is not intended to support continued development of novel agents or preclinical studies.
Closing date: February 10, 2021; October 13, 2021, by 5:00 PM local time of applicant organization.
Funding Opportunity Announcement (FOA): PAR-20-295
Secondary Analysis of Existing Datasets in Heart, Lung, and Blood Diseases and Sleep Disorders (R21 Clinical Trial Not Allowed), NIH
The goal of this funding opportunity is to stimulate the use of existing human datasets for well-focused secondary analyses to investigate novel scientific ideas or new models, systems, tools, methods, or technologies that have the potential for significant impact on biomedical or biobehavioral research in areas relevant to the NHLBI mission. This FOA actively supports the use of existing database resources to conduct additional analyses secondary to a project's originally-intended primary purpose. Applications may be related to, but must be distinct from, the specific aims of the original data collection. It will not support the collection of new data.
Closing date: October 28, 2020, February 26, 2021, October 28, 2021, February 26, 2022, October 28, 2022. All applications are due by 5:00 PM local time of applicant organization.
Funding Opportunity Announcement (FOA): PAR-20-078
Young investigator award, Tourette Association of America, US
The Tourette Association of America (TAA) aims to encourage early career researchers to invest their efforts and expertise in increasing our biological understanding of Tourette Syndrome (TS), pursing clinical research aimed at improving patient care, and developing and testing new therapies.
- The award is open to post-doctoral fellows, and independent clinical/research faculty members within 5 years of their first independent faculty appointment at the time of pre-proposal application submission.
- Investigators are required to have an advanced degree such as a Ph.D., M.D., or equivalent.
- Investigators outside the U.S. are welcome to apply.
- Investigators cannot have received previous early career funding support from the Tourette Association.
- Applications must include a career development component as well as an independent research project.
Budget: Up to $80,000 per year for a total of 2 years ($160,000 total). 10% INDI coverage.
Closing date: Pre-proposal due December 4, 2020. Full-proposal due February 1, 2021
Research grants, Oxalosis and Hyperoxaluria Foundation (OHF), US
The OHF seeks to support research that will ultimately lead to new diagnostics, treatments, and a
cure for Primary Hyperoxaluria and related Hyperoxaluria conditions.
Litwin IBD Pioneers supports researchers who are exploring all possible opportunities for diagnostic and therapeutic improvements, including novel, out-of-the-box ideas, and funds innovative and pioneering ideas that have a clinically relevant focus.
- Applicants must hold a MD, PhD. or equivalent by the time of the start of the funding period and have an appointment at an academic institution.
- Compliance with local and federal statutes and regulations of the country of origin must be met
Budget: $200,000.00 for up to two years. Indirect costs (10%) must be included in the maximum funding amount.
Closing date: December 15, 2020 at midnight ET